HAL advances “CATS Warrior” project: Manned-unmanned teaming for future air combat
[ad_1] Maharatna defence PSU Hindustan Aeronautics Ltd (HAL)’s futuristic Combat Air Teaming System (CATS) Warrior project has a novel technology development at its core –
ACME Solar Holdings posts ₹122 cr profit in Q4FY25
[ad_1] The company secured 1,900 MW projects during FY25 resulting in a total portfolio of 6,970 MW. It signed power purchase agreements (PPAs) for 1,890
Growth in credit card portfolio moderates in FY25
[ad_1] As per the data, total portfolio of banks under credit cards increased by 11.2 per cent at ₹28,7047 crore in FY 25 as on
Wheels India’s FY25 net profit crosses ₹100-cr mark
[ad_1] Srivats Ram, Managing Director, Wheels India Wheels India, a leading auto parts maker, has for the first time surpassed the ₹100-crore profit milestone in
Reduction in castorseed production may affect impact exports: SEA
[ad_1] In his monthly letter to the members of SEA on Tuesday, Sanjeev Asthana, SEA President, said India remains the world’s leading exporter of castor
TVS King EV MAX debuts with 179 km range, priced at ₹2.95 lakh
[ad_1] Electric autorickshaw TVS King EV MAX offers three driving modes—ECO, City, and Power—and charges up to 80 per cent in 2 hours and 15
Valuations have gone back to September-2024 peak: Trideep Bhattacharya, CIO, Edelweiss MF
[ad_1] Valuations, which had corrected earlier, have again “gone back to September-2024 peak” after the recent rally, said Trideep Bhattacharya, Chief Investment Officer, Edelweiss Mutual
Capital markets to grow steadily in FY26: smallcase
[ad_1] Capital markets are projected to grow steadily in FY26, aided by expected GDP growth of 6.2-6.5 per cent and domestic demand. As per smallcase
Broker’s call: Hyundai Motor (Buy)
[ad_1] Target: ₹2,050 CMP: ₹1,884.10 Hyundai Motor India Ltd’s (HMIL) Q4-FY25 EBITDA margin came in at 14.1 per cent, 200 bps above JMFe. 290 bps
Zydus Lifesciences Q4 Results: Net profit marginally declines to ₹1170.9 cr
[ad_1] The consolidated net profit of Zydus Lifesciences Ltd for the fourth quarter of financial year 2025 dropped marginally to ₹1,170.9 crore from the ₹1,182.3
